Skip to main content

Table 2 Logistic regression analysis for SPTBN1 expression and clinicopathological characteristics

From: SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner

Characteristics

Total(N)

Odds Ratio (OR)

P-Value

Age (> 60 vs. <  = 60)

539

0.694 (0.494–0.974)

0.035

Gender (male vs. female)

539

0.554 (0.385–0.793)

0.001

T stage (T2&T3&T4 vs. T1)

539

0.371 (0.261–0.524)

 < 0.001

N stage (N1 vs. N0)

257

0.359 (0.098–1.064)

0.083

M stage (M1 vs. M0)

506

0.363 (0.212–0.605)

 < 0.001

Stage (stage III&IV vs. stage I&II)

536

0.368 (0.256–0.527)

 < 0.001